Key Developments: Genpact Ltd (G.N)

G.N on New York Stock Exchange

26 Dec 2014
Price Change (% chg)

$-0.13 (-0.68%)
Prev Close
Day's High
Day's Low
Avg. Vol
52-wk High
52-wk Low

Search Stocks

Latest Key Developments (Source: Significant Developments)

Lombard Risk Management plc and Genpact to launch new collateral management solution
Friday, 21 Nov 2014 08:08am EST 

Lombard Risk Management plc:Enters into collaboration agreement with Genpact Limited, to provide the company's COLLINE collateral management product for new product solution.Genpact will integrate its Collateral Agreement and Reference Data Services (CARDS) with Lombard Risk's COLLINE collateral, clearing, inventory management and optimization solution.This solution will enable both buy and sell-side firms to automatically digitize and capture the terms and conditions of various collateral agreements across asset classes, counterparties, and business silos, resulting in a margin and collateral rulebook by counterparty.Lombard Risk and Genpact also intend to launch joint business processing outsourcing (BPO) service for their clients' collateral management function.  Full Article

Genpact Ltd sees FY 2014 revenue guidance at high end of prior range
Wednesday, 5 Nov 2014 04:05pm EST 

Genpact Ltd:Expect FY 2014 revenues to be at the high end of the previously announced range of $2.24 to $2.28 billion.FY 2014 revenue of $2.26 billion - Thomson Reuters I/B/E/S.  Full Article

Genpact Ltd expands business automation capabilities by partnering with Automic
Tuesday, 26 Aug 2014 08:00am EDT 

Genpact Ltd:Signed an alliance agreement with Automic.This new alliance is part of Genpact's strategy to embed innovative technology.Says technology facilitating IT and business operations by leveraging its Lean and Six Sigma-driven process expertise, domain knowledge and experience in running business operations and respective IT applications.  Full Article

Genpact Ltd raises FY 2014 revenue outlook
Thursday, 31 Jul 2014 04:04pm EDT 

Genpact Ltd:Expects FY 2014 revenues of $2.24 to $2.28 bln.FY 2014 revenue of $2.24 bln - Thomson Reuters I/B/E/S.  Full Article

Genpact Ltd to support Honeywell in Asian Markets
Tuesday, 22 Jul 2014 08:00am EDT 

Genpact Ltd:Enters into multi-year contract to deliver finance and accounting (F&A) services in the South East Asian markets for Honeywell, Fortune 100 diversified technology and manufacturing leader.Genpact provides range of business process services for manufacturing businesses including transformation, technology, analytics and outsourcing - applied to business functions spanning finance to aftermarket services.  Full Article

Genpact Ltd names Edward J. Fitzpatrick as Chief Financial Officer
Friday, 27 Jun 2014 09:00am EDT 

Genpact Ltd:Edward J. Fitzpatrick has been appointed chief financial officer effective July 15.He succeeds Mohit Bhatia.  Full Article

Genpact Ltd completes acquisition of Pharmalink Consulting
Thursday, 29 May 2014 04:05pm EDT 

Genpact Ltd:Says that it has closed its previously announced acquisition of Pharmalink Consulting.Now part of Genpact's growing life sciences vertical, the new business is named Genpact Pharmalink Global Regulatory Affairs.  Full Article

Genpact Ltd reaffirms FY 2014 revenue guidance
Monday, 5 May 2014 04:00pm EDT 

Genpact Ltd:Continues to expect FY 2014 revenues of $2.22 to $2.26 billion.FY 2014 revenue of $2.24 billion - Thomson Reuters I/B/E/S.  Full Article

Genpact Ltd, Oliver Wyman collaborate to expand portfolio of risk management solutions
Thursday, 24 Apr 2014 08:00am EDT 

Genpact Ltd and Oliver Wyman:Announces a collaboration to design and deliver new risk management solutions to the financial services industry.Collaboration will further expand the suite of offerings that each firm currently provides to this sector.  Full Article

Genpact Ltd to acquire Pharmalink Consulting-Business Standard
Thursday, 24 Apr 2014 02:42am EDT 

Genpact Ltd:Plans to acquire Pharmalink Consulting, provider of regulatory services in life sciences, for an undisclosed amount-Business Standard.  Full Article

No consensus analysis data available.
Search Stocks